Document Detail


APR-246 exhibits anti-leukemic activity and synergism with conventional chemotherapeutic drugs in acute myeloid leukemia cells.
MedLine Citation:
PMID:  21114538     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Background:  APR-246 belongs to a new generation of the compounds that restore normal p53 function in cells with mutated or wild type p53. The purpose of this study was to examine the effects of APR-246 alone and in combination with other drugs in acute myeloid leukemia (AML) cells. Methods:  Primary leukemic cells from patients with AML and AML cell lines were studied with respect to cytotoxic and apoptotic effects and mechanism of action of APR-246, alone and in combination with Ara-C, daunorubicin and fludarabine. Results:  APR-246 showed dose-dependent cytotoxic and apoptotic effects in AML cell lines as well as in primary AML patient cells. Cells from patients with TP53 mutation and complex karyotype were more resistant to conventional drugs while these factors did not significantly affect the sensitivity to APR-246. APR-246 increased active caspase-3, upregulated p53 protein levels, and increased the bax/bcl-2 ratio independently of TP53 mutational status in patient cells sensitive to APR-246. AML cells with high p14(ARF) expression were significantly more sensitive to APR-246. APR-246 induced significant synergistic effects in combination with conventional chemotherapeutic agents. Pre-incubation with APR-246 induced more synergistic effects compared to other schedules. In patient cells, pronounced synergism was found when combining APR-246 with danuorubicin. Conclusion:  We conclude that APR-246 is effective in AML cells irrespectively of TP53 mutational status and that it has promising properties for combination studies in AML.
Authors:
Dina Ali; Kerstin Jönsson-Videsäter; Stefan Deneberg; Sofia Bengtzén; Hareth Nahi; Christer Paul; Sören Lehmann
Related Documents :
15664198 - Human asf1 regulates the flow of s phase histones during replicational stress.
20460108 - Intracellular lysyl oxidase: effect of a specific inhibitor on nuclear mass in prolifer...
8505378 - Presence of a nuclear lamina in pachytene spermatocytes of the rat.
9436688 - Damaged chromatin does not prevent the exit from metaphase i in fused mouse oocytes.
8756058 - Hydrogen peroxide in the regulation of erythropoietin (epo) gene expression in hepatoce...
22742448 - Effect of human beta-defensin-3 on head and neck cancer cell migration using micro-fabr...
Publication Detail:
Type:  Journal Article     Date:  2011-01-11
Journal Detail:
Title:  European journal of haematology     Volume:  86     ISSN:  1600-0609     ISO Abbreviation:  Eur. J. Haematol.     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-02-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8703985     Medline TA:  Eur J Haematol     Country:  England    
Other Details:
Languages:  eng     Pagination:  206-15     Citation Subset:  IM    
Copyright Information:
© 2011 John Wiley & Sons A/S.
Affiliation:
Hematology Centre, Karolinska University Hospital, Huddinge, Stockholm, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  FLT3/?ITD regulates leukaemia cell adhesion through ?4?1 integrin and Pyk2 signalling.
Next Document:  Novel therapeutic strategies in multiple myeloma: role of the heat shock protein inhibitors.